Don't Jump to Newer Diabetes Meds for Renal Protection Yet

You may hear about using SGLT2 inhibitors (empagliflozin, etc) or GLP-1 agonists (liraglutide, etc) for renal protection in type 2 diabetes.

We know ACE inhibitors or ARBs slow progression of nephropathy in diabetes patients with hypertension and albuminuria.

Now growing data suggest certain SGLT2 inhibitors or GLP-1 agonists may also offer renal protection...independent of blood glucose lowering.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals